- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06100536
A Stand-alone Therapeutic Music-with-Movement Programme for People With Cognitive Impairment
The number of people living with cognitive impairment is increasing at an exponential rate. More than 100,000 older people are living with dementia in Hong Kong. Alarmingly, about 60% of long-term care residents or day-care centre users are living with dementia, nearly all of whom experience anxiety, depression, or other behavioural and psychological symptoms that place heavy demands on healthcare support and jeopardize their quality of life.
A standalone Music-with-Movement system is developed by integrating innovative and communication technology to facilitate the delivery of an evidence-based music-with-movement intervention. The technology employed are music library, 6-axis motion-sensing music instruments, wireless charging, and RFID.
This study aims to evaluate the changes in health outcomes (cognition, psychosocial well-being and perceived support) of older adults after receiving the service delivered by the trained staff using the standalone music-with-movement system.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Methods:
Aims and objectives:
- to evaluate the feasibility of the system supporting staff from elderly care institutes in leading musical activities (i.e., recruitment, retention, and acceptability);
- to evaluate the engagement of the participants in the intervention; and
- to preliminarily examine the health conditions of older adults with cognitive impairment.
Methods:
- Design: Single-group pre-and-post-test design
- Participants: Older adults with cognitive impairment.
- Setting: Elderly care institutes, such as daycare centres, community centres, and/or nursing homes.
- Sample size: 750 participants.
- Outcomes: Recruitment rate, attrition rate, acceptability, any adverse events, engagement in the intervention, health outcomes (social support, frailty, health-related QoL, MoCA).
- Data analysis strategies:
- Ethical consideration: Approval has been obtained from the University (HSEARS20211026009)
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Daphne Sze Ki Cheung, PhD
- Phone Number: 27664534
- Email: daphne.cheung@polyu.edu.hk
Study Contact Backup
- Name: Daphne Sze Ki Cheung, PhD
- Phone Number: 27664534
- Email: daphne.s.k.cheung@gmail.com
Study Locations
-
-
-
Hong Kong, Hong Kong
- Recruiting
- School of Nursing, The Hong Kong Polytechnic University
-
Contact:
- Daphne Cheung, PhD
- Phone Number: +852 27664534
- Email: daphne.cheung@polyu.edu.hk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Older adults with cognitive impairment
- In a stable medical condition
Exclusion Criteria:
- With critical medical or psychiatric problems
- Those with uncorrectable hearing impairment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Treatment group
Music-with-movement intervention supported by the stand-alone music-with-movement system.
|
The intervention group participants will receive 12 weekly music-with-movement interventions facilitated by trained staff in a community centre or a residential care home.
The duration lasts 30 minutes to one hour.
It can be carried out individually or with up to six persons in a group.
The intervention will be supported by the standalone music-with-movement system.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Recruitment Rate
Time Frame: through study completion, an average of 3 year
|
Recruitment rate-defined as the proportion of eligible participants (following screening) who agreed to take part in the study (calculated as number of participants recruited (numerator)/number of eligible participants (denominator)). Reference: Easpaig, B. N. G., Zhai, J., Gray, R., Brown, E., & Bressington, D. (2022). Recruitment, attrition and intervention completion in clinical trials of psychosocial interventions involving people with early and emerging psychosis: a systematic review protocol. BMJ open, 12(9), e060863. |
through study completion, an average of 3 year
|
|
Attribution Rate
Time Frame: through study completion, an average of 3 year
|
Attrition rate -defined as the proportion of participants at defined study points who discontinued the intervention or were lost to follow-up (calculated as number of participants that withdraw (numerator)/number of participants randomised (denominator)). Attrition rates will be calculated as three points: after randomisation, during the intervention and at final follow-up. Reference: Easpaig, B. N. G., Zhai, J., Gray, R., Brown, E., & Bressington, D. (2022). Recruitment, attrition and intervention completion in clinical trials of psychosocial interventions involving people with early and emerging psychosis: a systematic review protocol. BMJ open, 12(9), e060863. |
through study completion, an average of 3 year
|
|
Intervention completion rate
Time Frame: through study completion, an average of 3 year
|
Intervention completion rate - defined as the proportion of participants who completed the allocated intervention (for at least 70% attendance).
Calculated as number of participants allocated to the intervention that completed the minimum attendance (numerator)/number of participants allocated to treatment (denominator).
|
through study completion, an average of 3 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Multidimensional Scale of Perceived Social Support (MSPSS) Score
Time Frame: 6 months
|
The Multidimensional Scale of Perceived Social Support ("MSPSS") is a 12-item instrument designed to measure an individual's perception of support from 3 sources: family, friends and a significant other (4 items for each subscale) (Zimet et al., 1988), rated on a 7-point Likert scale ranging from "1" Very Strongly Disagree to "7" Very Strongly Agree.
|
6 months
|
|
Change in Frail Scale
Time Frame: 6 months
|
The scale is a short five-question assessment that can screen for frailty (Fatigue, Resistance, Ambulation, Illnesses, & Loss of Weight) (Abellan van Kan et al., 2008) .
Scores range from 0-5 (i.e., 1 point for each component; 0=best to 5=worst) and represent frail (3-5), pre-frail (1-2), and robust (0) health status.
|
6 months
|
|
Change in Montreal Cognitive Assessment 5-minute (MoCA)
Time Frame: 6 months
|
The 5-minute "Mini MoCA" is an abbreviated version of MoCA, composed of the tasks proven most sensitive to mild cognitive impairment.
The MoCA 5-min protocol in Cantonese version was validated to be reliable cognitive screening tools (Wong et al., 2015).
|
6 months
|
|
Change in Health-related Quality of Life (EQ-5D-3L)
Time Frame: 6 months
|
The EQ-5D-3L descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression (EuroQol Group).
Each dimension has 3 levels: no problems, some problems, and extreme problems.
The total score of five items can describe the patient's health state.
Also, the participants are asked to self-rating their health state on a vertical visual analogue scale (0 = the worst health state to 100 = the best health state) to reflect their own judgement.
|
6 months
|
|
Change in Neuropsychiatric Symptoms - Informant-based
Time Frame: 6 months
|
This is an informant-based instrument that measures the presence and severity of 12 neuropsychiatric symptoms in older adults with cognitive impairment and their associated distress over the previous month (Kaufer et al., 2000).
|
6 months
|
|
Engagement during the intervention
Time Frame: 3 months
|
Trained research assistant will observe the participants' engagement level during the intervention measured with Non-pharmacological Therapy Experience Scale (overall score ranges 0 - 30).
Higher score means better engagement.
|
3 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Daphne Sze Ki Cheung, PhD, The Hong Kong Polytechnic University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HSEARS20211026009
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cognitive Impairment
-
Stanford UniversityRecruitingMild Cognitive Impairment | Subjective Cognitive ImpairmentUnited States
-
University of EdinburghNHS LothianNot yet recruitingCognitive Impairment | Anesthesia | Cognitive Impairment, Mild | Anesthesia Brain Monitoring | Cognitive Impairment, Progressive | Anesthesia Depth MonitoringUnited Kingdom
-
Fondazione Don Carlo Gnocchi OnlusUniversity of Florence; Consorzio di Bioingeneria e Informatica Medica; Gutenberg...CompletedCognitive Dysfunction | Mild Cognitive Impairment | Vascular Cognitive ImpairmentItaly
-
University of California, Los AngelesCompletedMild Cognitive Impairment (MCI) | Age-associated Cognitive ImpairmentUnited States
-
Universidad de ZaragozaRecruitingMild Cognitive Impairment | Randomized Controlled Trial | Subjective Cognitive ImpairmentSpain
-
BaycrestCentre for Aging and Brain Health InnovationUnknownNeurocognitive Disorders | Cognitive Dysfunction | Mental Disorder | Cognitive Impairment, Mild | Cognitive Disorder | Nonamnestic Mild Cognitive ImpairmentCanada
-
Region SkaneLund University; Berry LabCompletedMemory Impairment | Cognitive Impairment, MildSweden
-
Sunnybrook Health Sciences CentreRecruitingMild Cognitive Impairment | Vascular Cognitive ImpairmentCanada
-
University of GeorgiaApplied Universal Dynamics, Corp.; Van Robotics, Inc.Active, not recruitingRobot-assisted Cognitive Training for Lonely Older Adults With Mild Cognitive Impairment (MCI) (MCI)Cognitive Change | Aging | Cognitive Impairment, MildUnited States
-
University of HawaiiRecruitingMild Cognitive Impairment | Subjective Cognitive ImpairmentUnited States
Clinical Trials on Music-with-movement
-
The Hong Kong Polytechnic UniversityNot yet recruitingChronic Pain | Pain Management | Elderly | Music-with-movement Exercise
-
The Hong Kong Polytechnic UniversityCompletedDepression | Quality of Life | Sleep | Dementia | AnxietyHong Kong
-
The Hong Kong Polytechnic UniversityCompleted
-
Ohio State UniversityHuntington's Disease Society of AmericaCompleted
-
University of Alabama at BirminghamThe Craig H. Neilsen Foundation; Lakeshore FoundationCompletedSpinal Cord InjuriesUnited States
-
Hanns LochmullerUniversity of OttawaRecruitingMyotonic Dystrophy Type 1 | Myotonic Dystrophy Type 1 (DM1) | Myotonic Dystrophy, Type 1 (DM1) | Myotonic Dystrophy, CongenitalCanada
-
University of Alabama at BirminghamAmerican Academy for Cerebral Palsy and Developmental MedicineCompletedCerebral PalsyUnited States
-
George Mason UniversityCompletedImpaired Cognition | EmotionUnited States
-
Edge Hill UniversityCompletedDementiaUnited Kingdom
-
Hasselt UniversityRevalidatie & MS Centrum OverpeltCompleted